Lymphoma Treatment Redefined

The landscape of lymphoma treatment has been fundamentally redefined, moving rapidly toward highly precise, chemotherapy-free regimens and advanced immunotherapies.
Event Information:

Date: Friday 30th April & Saturday 1st May, 2027

Location: Twin Towns, Coolangatta, Corner Of Griffith And, Stuart St, Coolangatta QLD 4225

Join us for our 2027 Lymphoma Australia National Health Professionals Conference on the Gold Coast, as we explore the cutting-edge innovations transforming patient care.
 
From targeted therapies and bispecific antibodies, to CAR T-cell therapies, this event brings together leading experts to share the latest clinical evidence, navigate complex treatment pathways, and share best practices.
 
Wherever you work with lymphoma patients in Australia, our two day agenda has something to empower you in optimising person-centered care.

Agenda

Subject to change, full agenda and presenters to be announced in the coming months.

Welcome and the Patient Experience

The Journey of a Drug: From Clinical Trials to the PBS

MORNING TEA

Rapid Fire: New Lymphoma Treatments

Rural, Regional and Remote Care

LUNCH

CAR T-Cell Therapy: Late Effects and Exploring Shared Care Models

Panel Discussion

AFTERNOON TEA

Rapid Fire: Indolent Lymphomas

Supportive Care and Immunoglobulins

NETWORKING  AND CANAPES

Welcome and the Patient Experience

Rapid Fire: Aggressive Lymphomas

MORNING TEA

Bispecific Antibodies: Supporting Safe Practice

Panel Discussion

LUNCH

The Younger Patient: Navigating Fertility and the AYA Experience

Survivorship: Life after Lymphoma

AFTERNOON TEA & CLOSE

PAST CONFERENCE GALLERY

2026 - Sydney

Contact Lymphoma Australia Today!

Please note:
Lymphoma Australia staff are only able to reply to emails sent in English language.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.